Agios Pharmaceuticals

David Schenkein, M.D. — Chief Executive Officer
Duncan Higgons — Chief Operating Officer
Scott Biller, Ph.D. — Chief Scientific Officer
Shin-San Michael Su, Ph.D. — SVP Research & Development
Glenn Goddard, C.P.A. — VP Finance
John Evans — VP Business Development & Operations
Camille Henderson, Ph.D. — Director of Human Resources

Bob Nelsen — ARCH Venture Partners
Doug Cole, M.D. — Flagship Ventures
Lewis C. Cantley, Ph.D. — Co-Founder
Kevin Starr — Third Rock Ventures
John Maraganore, Ph.D. — Alnylam Pharmaceuticals
Marc Tessier-Lavigne, Ph.D. — The Rockefeller University
Perry Karsen — Celgene Corporation